Increased PARylation impacts the DNA methylation process in type 2 diabetes mellitus
Open Access
- 17 May 2021
- journal article
- research article
- Published by Springer Nature in Clinical Epigenetics
- Vol. 13 (1) , 1-13
Abstract
Background: Epigenetic modifications, such as DNA methylation, can influence the genetic susceptibility to type 2 diabetes mellitus (T2DM) and the progression of the disease. Our previous studies demonstrated that the regulation of the DNA methylation pattern involves the poly(ADP-ribosyl)ation (PARylation) process, a post-translational modification of proteins catalysed by the poly(ADP-ribose) polymerase (PARP) enzymes. Experimental data showed that the hyperactivation of PARylation is associated with impaired glucose metabolism and the development of T2DM. Aims of this case–control study were to investigate the association between PARylation and global and site-specific DNA methylation in T2DM and to evaluate metabolic correlates. Results: Data were collected from 61 subjects affected by T2DM and 48 healthy individuals, recruited as controls. Global levels of poly(ADP-ribose) (PAR, a surrogate of PARP activity), cytosine methylation (5-methylcytosine, 5mC) and de-methylation intermediates 5-hydroxymethylcytosine (5hmC) and 5-formylcytosine (5fC) were determined in peripheral blood cells by ELISA-based methodologies. Site-specific DNA methylation profiling of SOCS3, SREBF1 and TXNIP candidate genes was performed by mass spectrometry-based bisulfite sequencing, methyl-sensitive endonucleases digestion and by DNA immuno-precipitation. T2DM subjects presented higher PAR levels than controls. In T2DM individuals, increased PAR levels were significantly associated with higher HbA1c levels and the accumulation of the de-methylation intermediates 5hmC and 5fC in the genome. In addition, T2DM patients with higher PAR levels showed reduced methylation with increased 5hmC and 5fC levels in specific SOCS3 sites, up-regulated SOCS3 expression compared to both T2DM subjects with low PAR levels and controls. Conclusions: This study demonstrates the activation of PARylation processes in patients with T2DM, particularly in those with poor glycaemic control. PARylation is linked to dysregulation of DNA methylation pattern via activation of the DNA de-methylation cascade and may be at the basis of the differential gene expression observed in presence of diabetes.Keywords
Funding Information
- Sapienza Università di Roma (RP11816432C6E003, RM11916B7A2348C8, RM120172AC70973A, AR11916B88F925F9, RM11916B811AFD26, RM1181643647A86E)
This publication has 62 references indexed in Scilit:
- Poly(ADP-ribosyl)ation Acts in the DNA Demethylation of Mouse Primordial Germ Cells Also with DNA Damage-Independent RolesPLOS ONE, 2012
- DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patientsThe EMBO Journal, 2012
- ADP-ribose polymers localized on Ctcf–Parp1–Dnmt1 complex prevent methylation of Ctcf target sitesBiochemical Journal, 2011
- Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral bloodHuman Molecular Genetics, 2011
- Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cellsGenome Research, 2011
- Liver-Specific Suppressor of Cytokine Signaling-3 Deletion in Mice Enhances Hepatic Insulin Sensitivity and Lipogenesis Resulting in Fatty Liver and ObesityHepatology, 2010
- Epigenetic Reprogramming of Mouse Germ Cells toward TotipotencyCold Spring Harbor Symposia on Quantitative Biology, 2010
- Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunctionBritish Journal of Pharmacology, 2009
- Parp1 Localizes within the Dnmt1 Promoter and Protects Its Unmethylated State by Its Enzymatic ActivityPLOS ONE, 2009
- CCCTC-binding Factor Activates PARP-1 Affecting DNA Methylation MachineryJournal of Biological Chemistry, 2008